CN Patent

CN104262458B — 一种与psma膜外区靶向性结合的多肽、放射性核素标记多肽及其应用

Assigned to Individual · Expires 2017-02-01 · 9y expired

What this patent protects

本发明属于医学领域，公开了一种与PSMA膜外区靶向性结合的多肽、放射性核素标记多肽及其应用。该多肽的氨基酸序列如SEQ ID No:1所示，该多肽通过偶联剂来介导放射性核素进行标记，可用于制备治疗或诊断前列腺癌的靶向性药物。

USPTO Abstract

本发明属于医学领域，公开了一种与PSMA膜外区靶向性结合的多肽、放射性核素标记多肽及其应用。该多肽的氨基酸序列如SEQ ID No:1所示，该多肽通过偶联剂来介导放射性核素进行标记，可用于制备治疗或诊断前列腺癌的靶向性药物。

Drugs covered by this patent

Patent Metadata

Patent number
CN104262458B
Jurisdiction
CN
Classification
—
Expires
2017-02-01
Drug substance claim
No
Drug product claim
No
Assignee
Individual
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.